gdc
PSS Guide 2023
CholangiocarcinomaFinancial Support

Drugs for Cholangiocarcinoma (Bile Duct Cancer)

Find financial assistance programs available for cholangiocarcinoma drugs.

Imfinzi (durvalumab)

Drug company: AstraZeneca
844-275-2360

AstraZeneca Access 360 offers 2 financial assistance programs for patients using Imfinzi:

Imfinzi Co-Pay Savings Program

AZ&Me Prescription Savings Program

Lytgobi (futibatinib) Tablets

Drug company: Taiho Oncology
844-824-4648

Taiho Oncology offers 1 financial assistance program for patients using Lytgobi:

Taiho Oncology Patient Support Program

Pemazyre (pemigatinib) Tablets

Drug company: Incyte
855-452-5234

IncyteCARES offers 3 financial assistance programs for patients who have been prescribed Pemazyre:

Pemazyre Savings Program

Pemazyre Patient Assistance Program

Pemazyre Temporary Access Program

Tibsovo (ivosidenib) Tablets

Drug company: Servier Pharmaceuticals
844-409-1141

Servier Pharmaceuticals, through ServierOne, offers 2 financial assistance programs for patients using Tibsovo:

Tibsovo Co-Pay Program

Patient Assistance Program

Table. Drugs Prescribed for Cholangiocarcinoma (Bile Duct Cancer)

  • Drug name (generic name)
  • Drug company
  • Indications
  • Patient support services

    Drug name (generic name)
  • Lytgobi (futibatinib) Tablets
  • Drug company
  • Taiho Oncology
  • Indication
  • Treatment of adults with previously treated, unresectable, locally advanced or metastatic intrahepatic cholangiocarcinoma harboring FGFR2 gene fusions or other rearrangements
  • Patient support services
  • Taiho Oncology Patient Support Program
    844-824-4648


    Drug name (generic name)
  • Tibsovo (ivosidenib) Tablets
  • Drug company
  • Servier Pharmaceuticals
  • Indication
  • Treatment of adults with previously treated locally advanced or metastatic cholangiocarcinoma and IDH1 mutation
  • Patient support services
  • Tibsovo Co-Pay Program
    844-409-1141

    Patient Assistance Program
    844-409-1141
Last modified: March 9, 2023

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message?

Help us fix it! Report broken links here.

Report Broken Link

Subscribe to Conquer: the journey informed

Receive timely cancer news & updates, patient stories, and more.


Country
Race or Ethnicity
Gender
Profession or Role
Primary Interest
Other Interests